Alexey Khrenov

Dr. Alexey Khrenov is currently Branch Chief in the Division of Hemostasis (DH), Office of Plasma Protein Therapeutics CMC (OPPT), in the Office of Therapeutic Products (OTP) in CBER/FDA. His branch is responsible for review of CMC sections of marketing and investigational applications, and supplements for plasma-derived and recombinant hemostatic products Dr. Khrenov has significant review experience and participated in multiple pre-license and surveillance inspections of manufacturing facilities. Dr. Khrenov is also a member of CBET Advanced Technology Team (CATT). He has been with the FDA for 11 years. Dr. Khrenov received his Ph.D. in Biochemistry from the Institute of Biochemical Physics of Russian Academy of Sciences in Moscow, Russia. Prior to joining the FDA Dr. Khrenov worked at the American Red Cross Holland Laboratory, United States Pharmacopeia and National Institutes of Health.